Baylis Medical's Kris Shah appointed to AdvaMed Accel Board of Directors

WASHINGTON, Oct. 25, 2017 /PRNewswire/ - Baylis Medical Company, a leading developer, manufacturer, and supplier of state-of-the-art interventional cardiology products, has announced that President and co-Founder Kris Shah has been named to the Advanced Medical Technology Association's (AdvaMed) Accel Board of Directors.

"I am honoured to be appointed to the AdvaMed Accel Board and look forward to working with this distinguished group of professionals to advance medical innovations that result in healthier lives and healthier economics around the world," said Mr. Shah. "I am particularly pleased to be joining an association that shares Baylis Medical's adherence to the highest ethical standards and commitment for improving patients' lives."

"We are pleased to have Kris joining our Accel Board of Directors," said Ashley Wittorf, Executive Director, AdvaMed Accel. "His business, engineering and commercialization experience bring a wealth of expertise to the Accel Board. In addition, his insight into international markets will be invaluable as we address the unique overseas challenges facing smaller medtech companies."

About Baylis Medical Company

Baylis Medical develops and markets high-technology medical devices used in the fields of interventional cardiology, interventional radiology, and spinal procedures. Our vision is to develop and market innovative medical therapies while improving the lives of people around the world. The company has offices in Montreal and Toronto (Canada), Boston (U.S.), London (U.K.) and Munich (Germany). For more information, visit

About AdvaMed Accel

AdvaMed Accel is the division within AdvaMed dedicated to addressing the unique needs and challenges of smaller medical device and diagnostics manufacturers - the lifeblood of the medical technology industry. The only organization of its kind focusing specifically on the needs of the medtech industry's emerging growth companies, AdvaMed Accel works to create a policy environment more conducive to capital formation and innovation. For more information, visit

PRM--00266 EN J-1,2,3 V-1 © Baylis Medical Company Inc., 2017. The Baylis Medical logo is a trademark and/or registered trademark of Baylis Medical Company Inc. in the USA and/or other countries.

SOURCE Baylis Médical